Delivery Order SPE2DB22D2218-SPE2DB24FR3CZ

Award Date 8/19/24
Potential Completion Date 8/20/24
Potential Value $2.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a Delivery Order issued to Amerisourcebergen Drug Corp's Corporate Office Division under the company's Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The IDC, valued at up to $999,999,999.00 through December 31, 2025, serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense (DoD) worldwide. This specific...
This is a Delivery Order under an Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a Ceiling Value of $95,115.00 and covers the delivery of a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits, to...
This is a delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract has a ceiling value of $1,954.56 and is a Firm Fixed Price, non-set-aside contract for the delivery of various pharmaceutical products and medical supplies to support military healthcare programs. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 25 milligram promethazine tablets. The fixed-price contract is valued at $2,065.35 and has a completion date of June 3, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary...
This is a delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) for the delivery of a variety of pharmaceutical products and medical supplies. The contract has a firm fixed price, with a ceiling value of $4,028.56, and a period of performance through May 13, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) on May 19, 2025. The contract has a firm fixed price and a ceiling value of $59,458.50, with a performance period ending on May 20, 2025. The delivery order is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which allows the company to supply...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The delivery order, valued at $1,427.51, is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, worth up to $999,999,999 and running through November 2026. This IDC enables the DLA to efficiently procure a comprehensive range of pharmaceutical products and...
This is a firm fixed price delivery order issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $25,195.56 order is for the provision of pharmaceutical products and medical supplies, including specialty, brand name, generic, and over-the-counter medications, as well as materials such as syringes, vials, test kits, and other critical care supplies. This delivery order is part of a larger indefinite...
This is a federal delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a ceiling value of $1,647.37 and is a firm-fixed-price delivery order with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999.00, which provides a comprehensive global...
This is a Delivery Order under a larger Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract, valued up to $999,999,999.00 through December 31, 2025, is the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the U.S. Department of Defense worldwide. This specific Delivery...
  • SPE2DB22D2218
    Indefinite Delivery Contract
  • SPE2DB22D2218-SPE2DB24FR3CZ
    Delivery Order

This is a delivery order under a larger Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract has a ceiling value of $2,086.81 and is for the delivery of 4,565,500,825 units of Promethazine 25 mg/ml vials. This delivery order does not have a set-aside designation. Amerisourcebergen holds a significant IDC with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for providing a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The company has also been awarded a separate IDC by the Department of Justice Federal Bureau of Investigation, valued at up to $750,000 through May 2024, for similar medical products and prescription drugs.

Generated 11/18/24, 9:29 AM